Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) — Cash Flow-to-Debt Ratio
Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) has a Cash Flow-to-Debt Ratio of -0.16x as of March 2026, meaning its operating cash flow of ₫-135.66 Billion could theoretically repay 0% of its total liabilities (₫870.62 Billion) in one year. Check DBD cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Binh Dinh Pharmaceutical and Medical Equipment JSC Cash Flow-to-Debt Ratio (2020–2025)
Historical debt coverage capacity for Binh Dinh Pharmaceutical and Medical Equipment JSC across 6 annual periods. Also explore DBD total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Binh Dinh Pharmaceutical and Medical Equipment JSC (2020–2025)
Year-by-year debt coverage analysis for Binh Dinh Pharmaceutical and Medical Equipment JSC. For market capitalisation and broader financial context, see DBD market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (VND) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.71x | ₫615.19 Billion | ₫862.89 Billion | ▲ +62.4% |
| 2024 | 0.44x | ₫264.73 Billion | ₫603.07 Billion | ▼ -17.0% |
| 2023 | 0.53x | ₫293.99 Billion | ₫556.07 Billion | ▲ +73.2% |
| 2022 | 0.31x | ₫165.01 Billion | ₫540.58 Billion | ▲ +8.8% |
| 2021 | 0.28x | ₫117.57 Billion | ₫418.97 Billion | ▼ -40.9% |
| 2020 | 0.47x | ₫212.91 Billion | ₫448.78 Billion | — |